Shwu-Fan Ma
Overview
Explore the profile of Shwu-Fan Ma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
3511
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chin D, Hernandez-Beeftink T, Donoghue L, Guillen-Guio B, Guillen-Uio B, Leavy O, et al.
medRxiv
. 2025 Feb;
PMID: 39974050
Background: Idiopathic pulmonary fibrosis (IPF) is a rare, incurable lung disease with a median survival of 3-5 years after diagnosis. Treatment options are limited. Genetic association studies can identify new...
2.
Alonso-Gonzalez A, Jaspez D, Lorenzo-Salazar J, Ma S, Strickland E, Mychaleckyj J, et al.
medRxiv
. 2024 Nov;
PMID: 39484282
Background: The clinical course of idiopathic pulmonary fibrosis (IPF) is highly variable and unpredictable, with multiple genetic variants influencing IPF outcomes. Notably, rare pathogenic variants in telomere-related genes are associated...
3.
Maddali M, Moore A, Sinha P, Newton C, Kim J, Adegunsoye A, et al.
Am J Respir Crit Care Med
. 2024 Jun;
210(4):455-464.
PMID: 38913573
Idiopathic pulmonary fibrosis (IPF) causes irreversible fibrosis of the lung parenchyma. Although antifibrotic therapy can slow IPF progression, treatment response is variable. There exists a critical need to develop a...
4.
Pugashetti J, Kim J, Bose S, Adegunsoye A, Linderholm A, Chen C, et al.
Am J Respir Crit Care Med
. 2024 Jun;
210(5):639-647.
PMID: 38843133
Accelerated biological aging has been implicated in the development of interstitial lung disease (ILD) and other diseases of aging but remains poorly understood. To identify plasma proteins that mediate the...
5.
Whalen W, Berger K, Kim J, Simmons W, Ma S, Kaner R, et al.
Am J Respir Crit Care Med
. 2024 May;
210(4):508-511.
PMID: 38762791
No abstract available.
6.
Huang Y, Ma S, Noth I
Am J Respir Crit Care Med
. 2024 May;
210(5):691-692.
PMID: 38701441
No abstract available.
7.
Hu X, Kim J, Saferali A, Huang Y, Ma S, Bingham G, et al.
Am J Respir Crit Care Med
. 2024 Apr;
210(5):683-686.
PMID: 38626378
No abstract available.
8.
Pugashetti J, Kim J, Combs M, Ma S, Adegunsoye A, Linderholm A, et al.
J Heart Lung Transplant
. 2024 Mar;
43(7):1174-1182.
PMID: 38556070
Background: Lung transplantation remains the sole curative option for patients with idiopathic pulmonary fibrosis (IPF), but donor organs remain scarce, and many eligible patients die before transplant. Tools to optimize...
9.
Huang Y, Ma S, Oldham J, Adegunsoye A, Zhu D, Murray S, et al.
Am J Respir Crit Care Med
. 2024 Feb;
210(4):444-454.
PMID: 38422478
Distinguishing connective tissue disease-associated interstitial lung disease (CTD-ILD) from idiopathic pulmonary fibrosis (IPF) can be clinically challenging. To identify proteins that separate and classify patients with CTD-ILD and those with...
10.
Guillen-Guio B, Paynton M, Allen R, Chin D, Donoghue L, Stockwell A, et al.
ERJ Open Res
. 2024 Feb;
10(1).
PMID: 38375425
Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial pneumonia marked by progressive lung fibrosis and a poor prognosis. Recent studies have highlighted the potential role of infection in the...